CSF2 and lymphoproliferative syndrome: The second study was a randomized one comparing the efficacy of a single dose of 40 μg HBV vaccine with one course of 40 μg HBV vaccine after 5 μg/kg recombinant GM-CSF injection in 94 patients with lymphoproliferative disorders (LPDs).